Bristol Cancer Institute wins service award
BIR president Andy Rogers, King’s College London medical physicist Jonathan Ashmore, Bristol Cancer Institute consultant clinical oncologist Dr Amar Challapalli and Bayer country head, radiology, Ruedeger Koehler.
A team from the Bristol Cancer Institute has won the BIR/Bayer Make it Better Award for its work on a new model of care to treat patients with prostate cancer.
Dr Amit Bahl and his team developed a service whereby cancer patients are treated with a new isotope treatment using Radium-223. This efficient treatment means patients attend far fewer appointments. The care model developed requires integration of the isotope service and the oncology team, who must have specific isotope and radiation safety training. The project team is also maximising uptake by training teams across the UK in areas that previously had no similar service.
The award was presented at the UKRCO meeting in Manchester. Consultant clinical oncologist Dr Amar Challapalli was given the award on behalf of the team by Bayer country head, radiology, Ruedeger Koehler and BIR president Andy Rogers.
See the full report on page 6 of the August 2017 issue of RAD Magazine.
